Provides information on a study on the inhibition of dipeptidyl peptidase IV activity by oral metformin in type 2 diabetes. Effect of metformin on patients with type 2 diabetes; Important gut hormone that enhance the insulin secretory response to feeding; Possibility that the drug may have potential for future combination therapy with incretin hormones.